Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAnthony Traboulsee, Brian G. Weinshenker, Benjamin Greenberg et al.|The Lancet Neurology|2020Cited by 495
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studiesReuben Benjamin, Jackie Chappell, Danielle Pinner et al.|The Lancet|2020Cited by 358
The human blue opsin promoter directs transgene expression in short-wave cones and bipolar cells in the mouse retina.J Chen, Emil Bogenmann, Chandra L. Tucker et al.|Proceedings of the National Academy of Sciences|1994Cited by 54